Infraredx is a renowned brand that specializes in intravascular imaging for mapping coronary artery disease. With a rich history spanning almost 30 years, they have become pioneers in the field by relentlessly pursuing innovative solutions for vascular disease. Infraredx offers a range of cutting-edge products and services designed to improve patient outcomes and revolutionize healthcare worldwide.

Their product lineup includes Clarispro™ HD-IVUS, Dualpro™ IVUS+, NIRS Makoto™ Imaging System, GM-30 Inflation Device, and OKAY II® Y-Connector. These advanced technologies enable physicians to better identify patients at high risk of cardiovascular disease and define new standards of care. In addition, Infraredx provides clinical evidence through studies like PROSPECT II & PROSPECT ABSORB Study and LRP Study, showcasing the effectiveness of their products.

Under the leadership of Nozomu Fujita, President and CEO, Infraredx has embraced the values of teamwork and the development of value-added products. Their Senior Vice President, Steve Sum, brings academic expertise and a passion for developing new ways to detect and evaluate vascular disease. To stay at the forefront of the industry, Infraredx actively participates in various events and seminars, providing educational sessions, webinars, and resources for healthcare professionals.

Their upcoming presence at AICT/AsiaPCR and TCT 2023 demonstrates their commitment to advancing the treatment of polyvascular disease patients. Infraredx continues to make strides in the field of intravascular imaging, shaping the future of healthcare and reshaping the boundaries of what is possible